BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 129705)

  • 1. Cellular immunity in myasthenia gravis. Response to purified acetylcholine receptor and autologous thymocytes.
    Richman DP; Patrick J; Arnason BG
    N Engl J Med; 1976 Mar; 294(13):694-8. PubMed ID: 129705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autologous mixed lymphocyte reaction in patients with myasthenia gravis: correlation with disease activity.
    Greenberg SJ; Olanow CW; Dawson DV; Crane B; Roses AD
    J Immunol; 1984 Mar; 132(3):1229-36. PubMed ID: 6229579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular immune response to acetylcholine receptor-rich fraction, in patients with myasthenia gravis.
    Abramsky O; Aharonov A; Webb C; Fuchs S
    Clin Exp Immunol; 1975 Jan; 19(1):11-6. PubMed ID: 1239345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased autologous mixed lymphocyte reaction in myasthenia gravis.
    Richards I; Harrison R; Lunt GG; Bowen JG
    J Clin Lab Immunol; 1986 May; 20(1):15-21. PubMed ID: 2942690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymic lymphocytes in myasthenia gravis.
    Birnbaum G; Tsairis P
    Ann Neurol; 1977 Apr; 1(4):331-3. PubMed ID: 152595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA, anti-DNA, and complement in myasthenia gravis.
    Christiansen FT; Houliston JB; Dawkins RL
    Muscle Nerve; 1978; 1(6):467-70. PubMed ID: 757869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphocyte responsiveness to acetylcholine receptor in rats with experimental autoimmune myasthenia gravis.
    Noguchi SA; Drachman DB; Adams RN; Hirsch RL
    Ann Neurol; 1980 Jul; 8(1):32-7. PubMed ID: 7406445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of humoral and cellular immune factors in neuromuscular block in myasthenia gravis.
    Namba T; Nakata Y; Grob D
    Ann N Y Acad Sci; 1976; 274():493-515. PubMed ID: 786115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two cases of thymoma-associated myasthenia gravis without antibodies to the acetylcholine receptor.
    Maggi L; Andreetta F; Antozzi C; Confalonieri P; Cornelio F; Scaioli V; Mantegazza R
    Neuromuscul Disord; 2008 Aug; 18(8):678-80. PubMed ID: 18657424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymus, thymoma and myasthenia gravis.
    Fujii Y
    Surg Today; 2013 May; 43(5):461-6. PubMed ID: 22948665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myasthenia gravis: mitotic activity of thymus-dependent and blood-lymphocytes.
    Szobor A; Staub M; Szathmáry I; Csuka I; Antoni F
    Acta Med Acad Sci Hung; 1976; 33(1):25-39. PubMed ID: 1088241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymus cells in myasthenia gravis selectively enhance production of anti-acetylcholine-receptor antibody by autologous blood lymphocytes.
    Newsom-Davis J; Willcox N; Calder L
    N Engl J Med; 1981 Nov; 305(22):1313-8. PubMed ID: 7290153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postthymectomy myasthenia gravis: relationship with thymoma and antiacetylcholine receptor antibody.
    Nakajima J; Murakawa T; Fukami T; Sano A; Takamoto S; Ohtsu H
    Ann Thorac Surg; 2008 Sep; 86(3):941-5. PubMed ID: 18721587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ryanodine receptor autoantibodies in myasthenia gravis patients with a thymoma.
    Mygland A; Tysnes OB; Matre R; Volpe P; Aarli JA; Gilhus NE
    Ann Neurol; 1992 Oct; 32(4):589-91. PubMed ID: 1333745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphocyte subpopulation in neoplastic and non-neoplastic thymus and in blood of patients with Myasthenia gravis.
    Shirai T; Miyata M; Nakase A; Itoh T
    Clin Exp Immunol; 1976 Oct; 26(1):118-23. PubMed ID: 1087211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of positive selection of thymoma-associated T cells in the pathogenesis of myasthenia gravis.
    Inada K; Okumura M; Shiono H; Inoue M; Kadota Y; Ohta M; Matsuda H
    J Surg Res; 2005 Jun; 126(1):34-40. PubMed ID: 15916972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell types required for anti-acetylcholine receptor antibody synthesis by cultured thymocytes and blood lymphocytes in myasthenia gravis.
    Willcox HN; Newsom-Davis J; Calder LR
    Clin Exp Immunol; 1984 Oct; 58(1):97-106. PubMed ID: 6236921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A potential role for B-cell activating factor in the pathogenesis of autoimmune myasthenia gravis.
    Ragheb S; Lisak R; Lewis R; Van Stavern G; Gonzales F; Simon K
    Arch Neurol; 2008 Oct; 65(10):1358-62. PubMed ID: 18852352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymyositis, myasthenic syndrome and thymoma in a patient with defective cell-mediated immunity.
    Ketz E; Fopp M; Weissert M; Bekier A
    Acta Neurol Belg; 1979; 79(6):469-74. PubMed ID: 317978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myasthenia gravis. Study of humoral immune mechanisms by passive transfer to mice.
    Toyka KV; Drachman DB; Griffin DE; Pestronk A; Winkelstein JA; Fishbeck KH; Kao I
    N Engl J Med; 1977 Jan; 296(3):125-31. PubMed ID: 831074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.